Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Peptide-Based Wound Dressing Kills Bacteria Efficiently

By HospiMedica International staff writers
Posted on 19 Aug 2020
An advanced wound dressing that contains cellulose membranes with bifunctional peptides shows potent antimicrobial activity, according to a new study.

Developed at the Swiss Federal Laboratories for Materials Science and Technology (Empa; Dübendorf, Switzerland), the dressings, made from plant‐derived cellulose fibers with a diameter of less than one micrometer, are electrospun into a delicate multi-layered, three-dimensional (3D) fabric that also contains the polymer polyurethane. More...
The cellulose membrane contains a bifunctional peptide which combines an antimicrobial peptide (AMP) and a cellulose binding peptide (CBP), with tight control over peptide concentrations.

The fiber scaffold of the fibroblast cytocompatible membranes are saturated with such bifunctional peptides, affecting bacteria via multiple modes of action, reducing evolutionary pressure selecting for antibiotic resistance. In cell cultures, the dressing exhibited a log4 reduction against Staphylococcus aureus, and a log1 reduction against Pseudomonas aeruginosa. In addition, using the cell adhesive CBP induced a 2.2‐fold increase in cell spreading, compared to pristine cellulose. The study was published in the July 2020 issue of Advanced Healthcare Materials.

“In bacterial cultures, over 99.99% of the germs were killed by the peptide-containing membranes. In future, the antimicrobial membranes will be equipped with additional functions,” said co-senior author Katharina Maniura-Weber, PhD, of the Empa Biointerfaces lab. “The peptides might, for instance, be functionalized with binding sites that enable the controlled release of further therapeutic substances.”

AMPs are potent, broad spectrum therapeutic agents that have been shown to kill both Gram positive and gram negative bacteria, enveloped viruses, fungi, and even some cancerous cells. Unlike antibiotic drugs, AMPs appears to destabilize biological membranes, can form transmembrane channels, and may have the ability to function as immunomodulators by altering host gene expression, inducing chemokine production, promoting wound healing, and modulating the responses of dendritic cells and cells of the adaptive immune response.

Related Links:

Swiss Federal Laboratories for Materials Science and Technology


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.